metastatic prostate cancer
Our blog features information and personal perspectives on topics of interest to the hereditary cancer community.
April 12, 2018
PARP Inhibitors and Hereditary Cancer: What’s New?
Posted in:
Research ,
Cancer Treatment
Tags:
BRCA ,
Ovarian Cancer ,
Genetic Testing ,
BRCA1 ,
BRCA2 ,
PALB2 ,
Pancreatic Cancer ,
ATM ,
Gene Panel Testing ,
Metastatic Breast Cancer ,
Ovarian Cancer Treatment ,
PARP Inhibitor ,
Cancer Research ,
Advanced Breast Cancer ,
Inherited Mutations ,
Prostate Cancer Treatment ,
Metastatic Prostate Cancer ,
Cancer Targeted Therapy
Most Recent
Volunteer Spotlight – Kate Small, Certified Genetic Counselor
My Thyroid Cancer Diagnosis: Eye-Opening Lessons in Personal and Patient Advocacy
De Madres a Hijas: Educating Latina Mothers and Daughters about HBOC Risk
A FORCE-Endorsed Resource is Updated and Expanded!
Embracing Hope and Unity: The Successful Introduction of Pink Ribbon Moms to Our Community
Subscribe to our Blog
Enter your email address to subscribe to this blog and receive a monthly digest of new posts.